SHL Telemedicine (LTS:0QMX) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QMX SHL Telemedicine Ltd LTS:0QMX
48 GF Score
Price CHF1.07
GF Value CHF1.26
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SHL Telemedicine Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


SHL Telemedicine  (LTS:0QMX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SHL Telemedicine Cyclically Adjusted PS Ratio Related Terms


SHL Telemedicine Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Cyclically Adjusted PS Ratio Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.90 3.50 1.60 0.61 0.49

SHL Telemedicine Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 0.61 0.42 0.49 0.41

LTS:0QMX vs VEEV, BTSG, TEM: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, SHL Telemedicine's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Cyclically Adjusted PS Ratio falls into.


LTS:0QMX
48GF Score
SHL Telemedicine Ltd LTS:0QMX
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SHL Telemedicine's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, SHL Telemedicine's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=2.274/324.0540*324.0540
=2.274

Current CPI (Dec25) = 324.0540.

SHL Telemedicine Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 2.094 241.432 2.811
201712 1.928 246.524 2.534
201812 2.501 251.233 3.226
201912 2.180 256.974 2.749
202012 1.974 260.474 2.456
202112 1.775 278.802 2.063
202212 2.131 296.797 2.327
202312 1.734 306.746 1.832
202412 1.678 315.605 1.723
202512 2.274 324.054 2.274

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is SHL Telemedicine (LTS:0QMX) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF1.07 is trading 15.1% below its estimated GF Value™ of CHF1.26. GuruFocus considers SHL Telemedicine to be Modestly Undervalued.

Key valuation signals for LTS:0QMX:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: CHF1.26 vs. price of CHF1.07 (15.1% below fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the LTS:0QMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SHL Telemedicine Business Description

Other Exchanges SHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
48GF Score

Get the complete analysis for LTS:0QMX

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1.07
Price
CHF1.26
GF Value